NasdaqCM:ALTO - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2025	1,244	17	15	45	2
12/31/2024	1,019	-13	-9	16	2
3/31/2024	1,150	-28	22	47	N/A
12/31/2023	1,223	-29	-8	22	N/A
9/30/2023	1,278	-43	-23	14	N/A
6/30/2023	1,297	-68	-73	-28	N/A
3/31/2023	1,341	-53	-73	-28	N/A
12/31/2022	1,336	-43	-32	6	N/A
9/30/2022	1,393	26	19	48	N/A
6/30/2022	1,361	51	22	43	N/A
3/31/2022	1,297	37	28	42	N/A
12/31/2021	1,208	44	10	27	N/A
9/30/2021	991	-12	-37	-24	N/A
6/30/2021	890	7	22	30	N/A
3/31/2021	804	13	31	40	N/A
12/31/2020	897	-16	65	72	N/A
9/30/2020	1,086	-37	74	80	N/A
6/30/2020	1,246	-80	44	48	N/A
3/31/2020	1,380	-102	15	19	N/A
12/31/2019	1,425	-90	-35	-31	N/A
9/30/2019	1,402	-81	-58	-52	N/A
6/30/2019	1,407	-61	-38	-29	N/A
3/31/2019	1,471	-67	-34	-22	N/A
12/31/2018	1,515	-62	-14	2	N/A
9/30/2018	1,576	-43	8	28	N/A
6/30/2018	1,651	-36	4	26	N/A
3/31/2018	1,646	-31	12	33	N/A
12/31/2017	1,632	-36	N/A	37	N/A
9/30/2017	1,679	-10	N/A	57	N/A
6/30/2017	1,651	-13	N/A	51	N/A
3/31/2017	1,669	1	N/A	54	N/A
12/31/2016	1,625	0	N/A	37	N/A
9/30/2016	1,560	-14	N/A	6	N/A
6/30/2016	1,523	-25	N/A	-37	N/A
3/31/2016	1,327	-29	N/A	-39	N/A
12/31/2015	1,191	-20	N/A	-28	N/A
9/30/2015	1,071	-7	N/A	-5	N/A
6/30/2015	966	11	N/A	48	N/A
3/31/2015	1,059	26	N/A	73	N/A
12/31/2014	1,107	19	N/A	88	N/A
9/30/2014	1,067	16	N/A	86	N/A
6/30/2014	1,025	7	N/A	69	N/A
3/31/2014	938	-7	N/A	44	N/A
12/31/2013	908	-2	N/A	14	N/A
9/30/2013	890	-16	N/A	-5	N/A
6/30/2013	872	-17	N/A	-18	N/A

애널리스트 미래 성장 예측

수입 대 저축률: ALTO 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 vs 시장: ALTO 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

고성장 수익: ALTO 향후 3년 동안 수익성이 없을 것으로 예상됩니다.

수익 대 시장: ALTO 의 수익(연간 5.5% ) US 시장( 8.7% 보다 느리게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: ALTO 의 수익(연간 5.5% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: ALTO 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

Alto Ingredients 미래 성장

Future 기준 확인 0/6

주요 정보

최근 미래 성장 업데이트

Consensus estimates of losses per share improve by 17%

Price target decreased by 16% to US$7.00

Consensus EPS estimates fall by 224%

Price target decreased to US$9.00

Consensus EPS estimates increase by 63%

Price target decreased to US$10.67

Recent updates

Consensus estimates of losses per share improve by 17%

First quarter 2024 earnings released: US$0.17 loss per share (vs US$0.18 loss in 1Q 2023)

Alto Ingredients, Inc. to Report Q1, 2024 Results on May 06, 2024

Alto Ingredients, Inc., Annual General Meeting, Jun 20, 2024

Alto Ingredients, Inc. Announces Executive Changes, Effective April 1, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Alto Ingredients, Inc. to Report Q4, 2023 Results on Mar 11, 2024

Here's Why Alto Ingredients (NASDAQ:ALTO) Can Afford Some Debt

Alto Ingredients, Inc. (NASDAQ:ALTO) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Share price stability

Alto Ingredients, Inc. to Report Q3, 2023 Results on Nov 06, 2023

Is Alto Ingredients (NASDAQ:ALTO) A Risky Investment?

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Alto Ingredients, Inc. Announces Chief Financial Officer Changes

Alto Ingredients, Inc. to Report Q2, 2023 Results on Aug 07, 2023

First quarter 2023 earnings released: US$0.091 loss per share (vs US$0.041 loss in 1Q 2022)

We Think Alto Ingredients (NASDAQ:ALTO) Has A Fair Chunk Of Debt

Price target decreased by 16% to US$7.00

Now 46% undervalued after recent price drop

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 224%

Independent Director recently bought US$95k worth of stock

Is Alto Ingredients (NASDAQ:ALTO) A Risky Investment?

Insufficient new directors

Price target decreased to US$9.00

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Alto Ingredients, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Now 22% undervalued after recent price drop

Alto Ingredients: The Decline Has Created A Buying Opportunity

Alto Ingredients, Inc. (NASDAQ: ALTO) announces an Equity Buyback Plan for $50 million worth of its shares.

Alto Ingredients gains on announcing $50M share repurchase program

Investor sentiment deteriorated over the past week

Alto Ingredients (NASDAQ:ALTO) Seems To Use Debt Quite Sensibly

Now 24% undervalued after recent price drop

Consensus EPS estimates increase by 63%

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improved over the past week

Alto Ingredients, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Alto Ingredients: Cheap For A Reason

Alto Ingredients, Inc. Announces Executive Changes

Investor sentiment deteriorated over the past week

With EPS Growth And More, Alto Ingredients (NASDAQ:ALTO) Makes An Interesting Case

Alto Ingredients, Inc. Announces Retirement of Christopher W. Wright as Senior Vice President

Independent Director recently bought US$81k worth of stock

Price target decreased to US$10.67

The Market Doesn't Like What It Sees From Alto Ingredients, Inc.'s (NASDAQ:ALTO) Earnings Yet As Shares Tumble 27%

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Alto Ingredients, Inc., Annual General Meeting, Jun 23, 2022

Investor sentiment deteriorated over the past week

Alto Ingredients: Its Customer-Centric Model May Push Up The Price

We Think Alto Ingredients (NASDAQ:ALTO) Can Manage Its Debt With Ease

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Alto Ingredients, Inc. to Report Q4, 2021 Results on Mar 10, 2022

Alto Ingredients, Inc. Appoints Auste M. Graham to the Senior Management Team as General Counsel and Corporate Secretary

Alto Ingredients Approaching Important Breakout

Alto Ingredients, Inc. (NasdaqCM:ALTO) acquired Eagle Alcohol Company LLC $29.3 million.

Alto Ingredients, Inc. Restarts its Magic Valley Facility

VP, General Counsel & Secretary recently sold US$375k worth of stock

Alto Ingredients: Bullish Into 2022 Turning Corn Into Gold

Third quarter 2021 earnings released: US$0.048 loss per share (vs US$0.26 profit in 3Q 2020)

Forecast to breakeven in 2021

Independent Director recently bought US$125k worth of stock

Alto Ingredients' (NASDAQ:ALTO) Shareholders May Want To Dig Deeper Than Statutory Profit

Consensus EPS estimates fall to US$0.51

Alto Ingredients, Inc. Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next

Second quarter 2021 earnings released: EPS US$0.11 (vs US$0.27 in 2Q 2020)

Alto Ingredients: Undervalued, Over-Shorted, Still Transforming